AgThera Inc.

company

About

General Probiotics develops innovative cellbots, antimicrobial probiotics that eliminate harmful pathogens in livestock.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Artificial Intelligence,Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

General Probiotics (GP) is a biotechnology company that discovers, develops and commercializes a new class of antimicrobial medicines for infectious diseases.

GP engineers are world leaders in advanced probiotics. GP probiotics are tailored to eliminate pathogens effectively and reliably.

GP has been awarded Small Business Innovative Research grants by the US National Science Foundation and the US Department of Agriculture to pursue an unparalleled, AI-enabled R&D program.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$1.38M
AgThera Inc. has raised a total of $1.38M in funding over 2 rounds. Their latest funding was raised on Sep 2, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 2, 2020 Grant $256K 1 National Science Foundation Detail
Aug 30, 2017 Grant $0.90M 1 National Science Foundation Detail
Jun 20, 2016 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
3
1
AgThera Inc. is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant